Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05361967 · ClinicalTrials.gov registry record
Tack Optimized Balloon Angioplasty Post-Market Study
A clinical trial, sponsored by Spectranetics Corporation.
- Terminated
- Registry status
- 6
- Enrollment target
NCT05361967: Clinical Trial study, sponsored by Spectranetics Corporation.
NCT05361967 is a clinical trial that was terminated before completion, run by Spectranetics Corporation. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05361967 was terminated before completion, sponsored by Spectranetics Corporation.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The objective of this study is to obtain outcomes following dissection repair with the Tack Endovascular System in a broad population of patients undergoing endovascular treatment of lesions within the superficial femoral, popliteal, peroneal, and/or tibial arteries.
Primary Outcome
Defined as demonstrated target lesion patency (\<30% residual diameter stenosis, by visual estimate) without the use of a bail out stent within the target lesion and without the occurrence of MALE + POD upon completion of the index procedure.
Interventions
- DEVICE The Tack Endovascular System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-03-30 |
| Est. Completion | 2024-06-01 |
Why NCT05361967 stopped before completion
NCT05361967 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which The Tack Endovascular System is the first listed.
NCT05361967 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05361967 about?
NCT05361967 is a clinical study titled "Tack Optimized Balloon Angioplasty Post-Market Study". The objective of this study is to obtain outcomes following dissection repair with the Tack Endovascular System in a broad population of patients undergoing endovascular treatment of lesions within the superficial femoral, popliteal, peroneal, and/or tibial arteries.
What is the current status of trial NCT05361967?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2023-03-30. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT05361967?
The interventions under investigation include: The Tack Endovascular System (DEVICE).
Who is sponsoring clinical trial NCT05361967?
This trial is sponsored by Spectranetics Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI